At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.53: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.61%
Annual Rate
USD 0.28Paid semi-annual
Payout Ratio
65.8%Moderate
Paying Dividends
2 yr
Last Ex-Dividend
Nov 19, 2026
Next Payment
Dec 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
446.85MUSD406.74M · vs all stocks (USD)
Trailing P/E
20.61xRevenue (TTM)
196.87MUSD181.68M · vs all stocks (USD)
Profit Margin
12.67%Beta
0.1990xvs all stocks
52-Week Change
14.67%vs all stocks
Forward Annual Dividend Yield
3.61%vs all stocks
Market Capitalization
446.85MUSD406.74M · vs all stocks (USD)
Enterprise Value
383.27MUSD345.18M · vs all stocks (USD)
Trailing P/E
20.61xForward P/E
13.50xPEG Ratio
0.8931xPrice to Sales (TTM)
2.30xPrice to Book (MRQ)
1.67xEnterprise to Revenue
1.95xEnterprise to EBITDA
8.67xGross Margin
40.91%Profit Margin
12.67%Operating Margin
15.43%Return on Assets (TTM)
5.00%Return on Equity (TTM)
9.35%Revenue (TTM)
196.87MUSD181.68M · vs all stocks (USD)
Revenue per Share (TTM)
3.40USDUpdated Nov 21, 2026Quarterly Revenue Growth
10.70%Gross Profit (TTM)
81.89MUSD74.77M · vs all stocks (USD)
EBITDA (TTM)
42.27MUSD39.71M · vs all stocks (USD)
Net Income (TTM)
24.95MUSD20.37M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
50.90%Operating Cash Flow (TTM)
45.21MUSD25.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
22.89MUSD11.08M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2800USDUpdated Nov 21, 2026Forward Annual Dividend Yield
3.61%vs all stocks
Trailing Annual Dividend Rate
0.3100USDUpdated Nov 21, 2026Trailing Annual Dividend Yield
4.00%vs all stocks
Payout Ratio
65.79%Revenue
180.46MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
104.05MUSDFY2025 · Dec 31, 2025Gross Profit
76.41MUSDFY2025 · Dec 31, 2025Operating Income
26.23MUSDvs all stocks (USD)
Pre-tax Income
23.47MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.27MUSDFY2025 · Dec 31, 2025Net Income
20.20MUSDFY2025 · Dec 31, 2025EBIT
24.33MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
40.42MUSDFY2025 · Dec 31, 2025Research & Development
12.99MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
33.84MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
1.92MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
864.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
0.3500USDFY2025 · Dec 31, 2025EPS (Diluted)
0.3500USDFY2025 · Dec 31, 2025Basic Shares Outstanding
57.71MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
57.71MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
20.20MUSDFY2025 · Dec 31, 2025Operating Cash Flow
23.36MUSDFY2025 · Dec 31, 2025Free Cash Flow
13.53MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
75.47MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
20.20MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
14.92MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
3.27MUSDFY2025 · Dec 31, 2025Stock-based Compensation
845.00KUSDFY2025 · Dec 31, 2025Other Non-cash Items
2.77MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.47MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-6.87MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.29MUSDFY2025 · Dec 31, 2025Capital Expenditures
-9.84MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-9.84MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-972.00KUSDFY2025 · Dec 31, 2025Common Dividends Paid
-11.53MUSDFY2025 · Dec 31, 2025Other Financing Charges
-5.89MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-18.39MUSDFY2025 · Dec 31, 2025Shares Outstanding
57.69MSharesUpdated Nov 21, 2026Float Shares
32.71MSharesUpdated Nov 21, 2026Shares Short
165.78KSharesUpdated Nov 21, 2026Short Ratio
2.22daysvs all stocks
Short % of Shares Outstanding
0.53%vs all stocks
% Held by Insiders
6.99%vs all stocks
% Held by Institutions
50.93%vs all stocks
Total Cash (MRQ)
75.32MUSD73.15M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.32USDUpdated Nov 21, 2026Total Debt (MRQ)
11.72MUSD11.64M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0437xCurrent Ratio (MRQ)
4.17xBook Value per Share (MRQ)
4.70USDUpdated Nov 21, 2026Total Assets
378.71MUSDvs all stocks (USD)
Total Current Assets
193.07MUSDFY2025 · Dec 31, 2025Total Liabilities
109.64MUSDFY2025 · Dec 31, 2025Total Non-current Assets
185.63MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
62.25MUSDFY2025 · Dec 31, 2025Total Current Liabilities
47.39MUSDFY2025 · Dec 31, 2025Cash
38.22MUSDFY2025 · Dec 31, 2025Cash Equivalents
37.25MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
75.47MUSDFY2025 · Dec 31, 2025Accounts Receivable
27.01MUSDFY2025 · Dec 31, 2025Inventory
84.94MUSDFY2025 · Dec 31, 2025Accounts Payable
23.24MUSDFY2025 · Dec 31, 2025Short-term Debt
2.12MUSDFY2025 · Dec 31, 2025Deferred Revenue
0.00USDFY2025 · Dec 31, 2025Other Current Liabilities
9.92MUSDFY2025 · Dec 31, 2025Long-term Debt
9.44MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
50.48MUSDFY2025 · Dec 31, 2025Common Stock (Book)
15.08MUSDFY2025 · Dec 31, 2025Retained Earnings
-17.07MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
269.07MUSDvs all stocks (USD)
52-Week Low
6.60USDUpdated Nov 21, 202652-Week High
9.35USDUpdated Nov 21, 202652-Week Change
14.67%vs all stocks
Beta
0.1990xvs all stocks
50-Day MA
8.03USDUpdated Nov 21, 2026200-Day MA
7.99USDUpdated Nov 21, 2026Avg 10-Day Volume
129.57KSharesUpdated Nov 21, 2026Avg 30-Day Volume
106.55KSharesUpdated Nov 21, 2026Diluted EPS (TTM)
0.3800USDUpdated Nov 21, 2026Other Income / Expense
-3.82MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.53: safe zoneNotable
Altman Z-Score: 3.53
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Universal Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Yantai Zhenghai Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Panlong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Haisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Seers Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Medlander Medical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Tibet Aim Pharm Inc.
Tier 1ProductionApproval-Gated PipelineRule
Assembly Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Jiaoda Onlly Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule